Skip to main content
EuroIntervention logoLink to EuroIntervention
. 2022 Mar 18;17(16):1313–1317. doi: 10.4244/EIJ-D-21-00694

How to set up regional STEMI networks: a "Stent - Save a life!" initiative

Alfonsina Candiello 1, Thomas Alexander 2, Rhena Delport 3, Gabor G Toth 4, Paul Ong 5, Adriaan Snyders 6, Jorge A Belardi 7, Michael KY Lee 8, Helder Pereira 9, Awad Mohamed 10, Jorge Mayol 11, Jan J Piek 12, William Wijns 13, Andreas Baumbach 14, Christoph Naber 15,*
PMCID: PMC9743232  PMID: 34387547

Abstract

Clinical guidelines recommend the development of ST-elevation myocardial infarction (STEMI) networks at community, regional and/or national level to ideally offer primary coronary angioplasty, or at least the best available STEMI care to all patients. However, there is a discrepancy between this clinical recommendation and daily practice, with no coordinated care for STEMI patients in many regions of the world. While this can be a consequence of lack of resources, in reality it is more frequently a lack of organisational power. In this paper, the Stent - Save a Life! Initiative (www.stentsavealife.com) proposes a practical methodology to set up a STEMI network effectively in any region of the world with existing resources, and to develop the STEMI network continuously once it has been established.

Introduction

Primary percutaneous coronary intervention (pPCI) is the preferred reperfusion therapy for patients presenting with ST-elevation myocardial infarction (STEMI), as recommended by clinical guidelines1. pPCI is clearly superior to all other treatments investigated to date regarding mortality and morbidity and, in addition, is cost saving for national economies2. All healthcare systems should aim to provide pPCI to all STEMI patients, independent of location, nationality, race, sex or personal wealth. As a first step, available resources should be organised to provide the best available care to all patients and to optimise STEMI management nationwide. To reach this goal, systems of care for STEMI management need to be developed at a community, regional and/or national level3,4,5. This document proposes a universal methodology to provide the best available, guideline-adherent care for STEMI patients based on five general assumptions (Table 1).

Table 1. Key factors for any STEMI network.

Factor Assumption
Players The relevant stakeholders in any STEMI network are: patient and family, GP/GC, EMS, non-pPCI hospital, and pPCI-hospital.
Roles The roles of the players are defined by i) evidence-based clinical guidance, and ii) the presence or absence of other players.
Scenarios The existing players and their roles determine the number of possible scenarios for any network.
Treatment options A given scenario always defines the best available therapeutic option in a region for STEMI patients.
Quality metrics Continuous monitoring and feedback is key to improving the network.
EMS: emergency medical services; GP/GC: general practitioner/general cardiologist; pPCI: primary percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction

Review of clinical guidelines

Therapeutic options

Reperfusion of the myocardium by pPCI within 12 hours of symptom onset is the cornerstone of STEMI treatment, followed by a pharmacoinvasive strategy (PI) if pPCI cannot be performed within 120 minutes of diagnosis, or, if the latter is also not available, stand-alone fibrinolysis. In any PI or lysis strategy, patients should be transferred urgently to a percutaneous coronary intervention (PCI) centre after lysis1,6,7,8.

Choice and timing of the optimal therapy

As a first step, all healthcare systems should develop regional networks of care for STEMI patients to counter regional disparities as much as possible9. Until timely pPCI can be provided to all patients, the preferred reperfusion strategy for each patient will depend on local resources, timing, and the entry point into the network (Figure 1, Table 2, Supplementary Table 1).

Figure 1. Recommended reperfusion strategies according to timing and point of entry to the network.

Figure 1

ECG: electrocardiogram; EMS: emergency medical services; FL: fibrinolysis; FMC: first medical contact; GP/GC: general practitioner/general cardiologist; min: minutes; PCI: percutaneous coronary intervention; pPCI: primary percutaneous coronary intervention

Table2. Definition of important time points and intervals in STEMI networks.
Time period Abbreviation Definition
First medical contact FMC Time point when the patient is initially assessed by a physician, paramedic, nurse or trained EMS personnel who can obtain and interpret the ECG and deliver initial interventions. FMC can be in the pre-hospital setting or upon arrival at the hospital. In all scenarios, STEMI diagnosis via ECG should be obtained within 10 minutes.
Time of reperfusion TOR The time point of either a wire crossing the occlusion or the start of administration of lytic therapy.
Total ischaemic time TIT The time from symptom onset until reperfusion is a strong predictor of patient outcomes. TIT comprises patient delay and system delay.
Patient delay PD Time interval between symptom onset and FMC.
System delay SD Time interval between FMC and time of reperfusion.
Door-in-door-out time DIDO Time between patient arrival in a non-pPCI centre and the transfer to a pPCI centre.
ECG: electrocardiogram; EMS: emergency medical services; pPCI: primary percutaneous coronary intervention; STEMI: ST-segment elevation infarction

Characteristics, elements and roles in a STEMI network

Only an effectively organised STEMI network will ensure that all STEMI patients will be optimally treated within the window of opportunity. All resources and processes in a region should be organised to serve this single purpose.

Main characteristics of a STEMI network

  • 24/7 treatment service for all STEMI patients

  • structured cooperation among all parties involved following standardised protocols

  • regular structured meetings and continuous education of all parties involved

  • continuous self-assessment and improvement of the network.

Main players in a STEMI network

Patients

Ideally patients should be able to recognise symptoms of myocardial infarction and understand the importance of receiving urgent treatment. They should understand how to activate the emergency medical services (EMS) or otherwise seek immediate medical attention (Supplementary Table 2).

General practitioner/general cardiologist (GP/GC)

GPs/GCs play an important role as first responders to patient consultations. GPs/GCs should be integrated into a STEMI network and should be able to recognise and manage patients with STEMI according to standardised protocols (Supplementary Table 2).

Emergency medical services

EMS are important coordinators of the referral pathway3,10. Their main actions entail pre-hospital patient management and between-hospital transfers. An EMS should always coordinate its actions with the network and notify the receiving hospital prior to arrival to check capacities and allow preparation. Ideally, all EMS should be centralised and activated through a single and well-publicised dispatch telephone number1 (Supplementary Figure 1, Supplementary Table 2).

Non-pPCI centres and hospitals without PCI facilities

These centres receive STEMI patients through two different pathways - directly from home or the community, or via transfer by EMS. Non-pPCI centres should diagnose a STEMI within 10 minutes after the patient’s arrival and perform pPCI or transfer to a pPCI centre, or handle a PI strategy (Supplementary Figure 2, Supplementary Table 2).

Primary PCI centres

pPCI centres receive STEMI patients through one of three pathways - directly from home or the community, via transfer by EMS, or by secondary transportation from a non-pPCI centre. They should have a mandatory 24/7 cath lab available within 30 minutes of activation. They are obliged to operate a “non-refusal” admission policy (Supplementary Figure 3, Supplementary Table 2).

Setting up a STEMI network

Despite national or regional challenges, the implementation of a STEMI network is always similar.

Stage 1. Preparation phase

The first step is to set up a local task force and an action plan for developing the network. This task force is also responsible for assigning roles, developing standard protocols for diagnosis and treatment in cooperation with the regional stakeholders and, later, coordinating the network.

Stage 2. Mapping phase

In this phase, the task force identifies all potential pPCI and non-pPCI centres, estimates the distances and the time needed for transportation, checks the availability of EMS and contacts the centres and the EMS to confirm their willingness to participate and their ability to cope with the demands. All these resources should be mapped to understand the regional situation and to determine the best possible layout of regional network(s).

Stage 3. Building phase

Following the assumption that the role of each player in any network is always defined by the presence or absence of other players, any network can be categorised following the specifications in Table 3 and the Central illustration. The task force assigns the individual roles to each player and nominates the coordinators of the centres, the EMS, and the GP/GC groups.

Table 3. Network types according to existing resources.
Primary PCI networks
Ranking Optimal long-term solution for STEMI care.
Mandatory resources pPCI centres which can be reached within 90 min after symptom onset or diagnosis of STEMI; EMS coordinated with the network.
Primary therapies offered pPCI 24/7.
If the pPCI centre is occupied or has a technical failure, a PI strategy is offered if pPCI cannot be offered within guideline-coherent timelines.
Processes The EMS should bypass all other centres and transfer STEMI patients directly to the closest pPCI centre.
Hub-and-spoke PCI networks
Ranking Acceptable long-term solution for STEMI care.
Mandatory resources pPCI centres; non-pPCI centres; EMS coordinated with the network.
Primary therapies offered pPCI, PI strategy.
Processes This model comprises two zones: the inner zone resembles a primary PCI network, the outer zone consists of non-pPCI centres or non-PCI hospitals which are connected to the inner zone via an EMS. They offer a PI strategy and either transfer the patient for PCI or perform PCI in the same place during office hours following the recommended timelines.
Important steps to upgrade Turn non-pPCI centres into pPCI centres.
Pharmacoinvasive networks
Ranking Transient solution for STEMI care, should be upgraded in the midterm.
Mandatory resources non-pPCI centres; an EMS, coordinated with the network, is highly desirable.
Primary therapies offered PI strategy; primary PCI if patient arrives at PCI centre during office hours.
Processes These networks offer a PI strategy 24/7 with fibrinolysis in all connected hospitals and either transfer the patient for PCI or perform PCI during office hours. pPCI is offered if patients arrive in a PCI hospital during office hours.
Important steps to upgrade 1. Introduce an EMS, coordinated with the network.
2. Turn non-pPCI centres into 24/7 pPCI centres.
Fibrinolysis networks
Ranking Transient organisation which provides basic care for STEMI patients. Should be upgraded as early as possible.
Mandatory resources Medical centres without PCI option, able to recognise a STEMI and handle fibrinolysis; an EMS, coordinated with the network is highly desirable; a remote ECG interpretation service can be useful.
Primary therapies offered Stand-alone fibrinolysis.
Processes These networks offer application of fibrinolysis 24/7.
Important steps to upgrade 1. Introduce an EMS, coordinated with the network.
2. Install cath labs and expand their service to 24/7 pPCI.
cath lab: cardiac catheterisation laboratory; ECG: electrocardiogram; EMS: emergency medical service; FMC: first medical contact; PCI: percutaneous coronary intervention; PI: pharmacoinvasive; pPCI: primary percutaneous coronary intervention; STEMI: ST-elevation myocardial infarction
Central illustration. Typical combination of a hub-and-spoke network with an inner zone (green circle) organised as a pPCI network and an outer zone following a PI strategy (blue circle).

Central illustration

The external purple zone represents a fibrinolysis network with no PCI centre in reach. GP/GC: general practitioner/general cardiologist; PI: pharmacoinvasive; pPCI: primary percutaneous coronary intervention

Stage 4. Quality assessment and continuous education phase

Quality assessment

At least one basic set (Supplementary Table 3, Supplementary Table 4) of quality variables should be established7. This refers to the performance parameters of all network components and includes, e.g., presentation timing, rate of patients treated, procedural success and in-hospital mortality. The task force should meet periodically to analyse the performance and discuss necessary adaptations. The connection of reimbursement and compliance with standards can be a relevant steering instrument11. One question that remains unanswered is whether having too many pPCI centres in a region may be disadvantageous, since each single centre could end up having not enough experience and routine practice.

Continuous education for professionals

Not all professionals involved have a basic training in cardiology. It may be important to offer specific educational and training programmes for paramedics, nurses, technicians and non-cardiology physicians on a recurrent basis due to staff rotation.

Population awareness campaigns

Patient awareness of indicative symptoms and knowledge of how to seek medical attention effectively is key for the success of a STEMI network programme, since the longest delays are usually caused by the patients12. Awareness programmes involving social media, the entertainment industry, community organisations and scientific associations may be helpful; however, their effects quickly fade once they are discontinued13.

Conclusions

The implementation of regional STEMI care systems overcomes local barriers and guarantees the best available reperfusion treatment for STEMI patients. A coordinated network of all stakeholders, guided by evidence-based, standardised protocols with a clear definition of roles and responsibilities is key and should be accompanied by a process of continuous improvement through evaluation of quality measures.

References

The list of references can be found in Supplementary Appendix 1.

Supplementary data

Supplementary Appendix 1

References.

Supplementary Table 1

Reperfusion strategy of choice depending on the actual or estimated time period to reperfusion in STEMI networks.

Supplementary Table 2

Players in a STEMI network and their roles.

Supplementary Table 3

Minimal set of variables to be continuously monitored by all STEMI networks.

Supplementary Table 4

Target zones for quality metrics.

Supplementary Figure 1

Recommended actions in patients presenting via EMS according to system delay from STEMI diagnosis to pPCI.

Supplementary Figure 2

Recommended actions and reperfusion strategies for patients presenting at a non-PCI centre.

Supplementary Figure 3

Recommended actions and reperfusion strategy for patients presenting at a pPCI centre.

Acknowledgments

Conflict of interest statement

The authors have no conflicts of interest to declare.

Abbreviations

ACC/AHA

American College of Cardiology/American Heart Association

cath lab

cardiac catheterisation laboratory

EMS

emergency medical services

ESC

European Society of Cardiology

FMC

first medical contact

GP/GC

general practitioner/general cardiologist

LMIC

low- and middle-income countries

PI

pharmacoinvasive

PCI

percutaneous coronary intervention

pPCI

primary percutaneous coronary intervention

SSL

Stent - Save a Life!

STEMI

ST-elevation myocardial infarction

TIT

total ischaemic time

Contributor Information

Alfonsina Candiello, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Thomas Alexander, Kovai Medical Center, Coimbatore, India.

Rhena Delport, Department of Family Medicine, School of Medicine, University of Pretoria, Pretoria, South Africa.

Gabor G. Toth, University Heart Center Graz, Division of Cardiology, Department of Medicine, Medical University Graz, Graz, Austria.

Paul Ong, Tan Tock Seng Hospital, Singapore, Singapore.

Adriaan Snyders, Wilgers Hospital, Pretoria, Gauteng, South Africa.

Jorge A. Belardi, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Michael K.Y. Lee, Division of Cardiology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.

Helder Pereira, Hospital Garcia de Orta, Almada, Portugal.

Awad Mohamed, Department of Medicine, University of Khartoum, Khartoum, Sudan.

Jorge Mayol, Centro Cardiológico Americano, Montevideo, Uruguay.

Jan J. Piek, Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

William Wijns, The Lambe Institute for Translational Medicine and CÚRAM, National University of Ireland Galway, Galway, Ireland.

Andreas Baumbach, Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.

Christoph Naber, Klinikum Wilhelmshaven, Wilhelmshaven, Germany.

References

  1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77. doi: 10.1093/eurheartj/ehx393. [DOI] [PubMed] [Google Scholar]
  2. Wein B, Bashkireva A, Au-Yeung A, Yoculan A, Vinereanu D, Deleanu D, Pereira H, Pereira E, de Mello, Rumoroso JR, Ganyukov V, Wijns W, Naber CK. Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo Region. Eur Heart J Acute Cardiovasc Care. 2020;9:902–10. doi: 10.1177/2048872619853959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kalla K, Kamik R, Malzer R, Norman G, Prachar H, Schereiber W, Unger G, Goglar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006;113:2398–405. doi: 10.1161/CIRCULATIONAHA.105.586198. [DOI] [PubMed] [Google Scholar]
  4. Henry TD, Sarkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT, Wang YL, Larson DM. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721–8. doi: 10.1161/CIRCULATIONAHA.107.694141. [DOI] [PubMed] [Google Scholar]
  5. Alexander T, Mullasari A, Joseph G, Kannan K, Veerasekar G, Victor S, Ayers C, Thomson S, Subban V, Gnanaraj JP, Narula J, Kumbhani D, Nallamothu BK. A System of Care for Patients with ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program. JAMA Cardiol. 2017;2:498–505. doi: 10.1001/jamacardio.2016.5977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. O´Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Omato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Stevenson WG, Yancy CW American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–425. doi: 10.1161/CIR.0b013e3182742cf6. [DOI] [PubMed] [Google Scholar]
  7. Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults with ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70:2048–90. doi: 10.1016/j.jacc.2017.06.032. [DOI] [PubMed] [Google Scholar]
  8. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. doi: 10.1093/eurheartj/ehy394. [DOI] [PubMed] [Google Scholar]
  9. Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario, Wijns W, Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer, Claeys MJ, Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T, Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D, Najafov R, Nicolini FA, Noč M, Ostojic M, Pereira H, Radovanovic D, Sabaté M, Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J. 2014;35:1957–70. doi: 10.1093/eurheartj/eht529. [DOI] [PubMed] [Google Scholar]
  10. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361:13–20. doi: 10.1016/S0140-6736(03)12113-7. [DOI] [PubMed] [Google Scholar]
  11. Kristensen SD, Fajadet J, Di Mario, Kaifoszova Z, Laut KG, Deleanu D, Gilard M, Guagliumi G, Goktekin O, Jorgova J, Kanakakis J, Ostojic M, Pereira H, Sabate M, Sobhy M, Vrints C, Wijns W, Widimsky P. Implementation of primary angioplasty in Europe: stent for life initiative progress report. EuroIntervention. 2012;8:35–42. doi: 10.4244/EIJV8I1A7. [DOI] [PubMed] [Google Scholar]
  12. Pereira H, Calé R, Pinto FJ, Pereira E, Caldeira D, Mello S, Vitorino S, de Sousa, Mimoso J centers participating in the Stent for Life Initiative Portugal. Factors influencing patient delay before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The Stent for life initiative in Portugal. Rev Port Cardiol (Engl Ed) 2018;37:409–21. doi: 10.1016/j.repc.2017.07.014. [DOI] [PubMed] [Google Scholar]
  13. Knot J, Widimsky P, Stenestrand U, Kristensen SD, Van’ T Hof A, Weidinger F, Janzon M, Nörgaard BL, Soerensen JT, van de Wetering H, Thygesen K, Bergsten PA, Digerfeldt C, Potgieter A, Tomer N, Fajadet J. How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention. 2009;5:301–9. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Appendix 1

References.

Supplementary Table 1

Reperfusion strategy of choice depending on the actual or estimated time period to reperfusion in STEMI networks.

Supplementary Table 2

Players in a STEMI network and their roles.

Supplementary Table 3

Minimal set of variables to be continuously monitored by all STEMI networks.

Supplementary Table 4

Target zones for quality metrics.

Supplementary Figure 1

Recommended actions in patients presenting via EMS according to system delay from STEMI diagnosis to pPCI.

Supplementary Figure 2

Recommended actions and reperfusion strategies for patients presenting at a non-PCI centre.

Supplementary Figure 3

Recommended actions and reperfusion strategy for patients presenting at a pPCI centre.


Articles from EuroIntervention are provided here courtesy of Europa Group

RESOURCES